We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Notice of Temporary Suspension of Imports for the Medications Haldol (haloperidol) and...
Thursday 5th February 2026
In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), the company Moksha8 Brasil Indústria...
Report on Transparency and Pay Equity Between Women and Men
Wednesday 31st December 2025
Notice of Registration Cancellation for the Drug Ultraproct LDO (fluocortolone pivalate, lidocaine...
Thursday 13th November 2025
In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), Moksha8 Brasil Indústria e Comércio...
Notice of Lisodren’s Registration Cancellation
Monday 6th January 2025
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda (“M8 Pharmaceuticals”) announces that on May 7, 2024, it requested that the...
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Acino Publishes Second Annual Sustainability Report
Tuesday 1st October 2024
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...
Acino Recognizes World Heart Day 2024
Sunday 29th September 2024
Acino reaffirms its commitment to advancing cardiovascular health in emerging markets and beyond.
Acino signs an exclusive agreement with LG Chem for Novel Treatments for...
Wednesday 24th July 2024
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...
Your partner for innovative medicines in emerging markets
Wednesday 26th June 2024
We have expanded our portfolio with several novel products, marking a significant step forward in our effort to help more...
Acino signs an exclusive license agreement with Supernus in Latin America
Tuesday 7th May 2024
Acino will collaborate with Supernus to develop and commercialize products for the treatment of diseases of the central nervous system...